UVM/FAHC — Burlington, Vermont

UVM/FAHC is a clinical research site located in Burlington, Vermont, United States 05401.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

UVM/FAHC has participated in 3 clinical trials.

Therapeutic areas: Neuroblastoma, Refractory Neuroblastoma, Relapsed Neuroblastoma.

Sponsors: Giselle Sholler.

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UVM/FAHC?

UVM/FAHC has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UVM/FAHC conducted?

UVM/FAHC has 3 clinical trials on record. Their work covers Neuroblastoma, Refractory Neuroblastoma, Relapsed Neuroblastoma.

Is UVM/FAHC accredited by Crixeo Health?

UVM/FAHC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UVM/FAHC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.